Literature DB >> 29559717

Therapy: Arming the regulators - new strategies to treat autoimmunity.

Richard O Williams1, Wen-Yi Tseng1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29559717     DOI： 10.1038/nrrheum.2018.50

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

Review 1.  Hurdles in therapy with regulatory T cells.

Authors:  Piotr Trzonkowski; Rosa Bacchetta; Manuela Battaglia; David Berglund; Hermann Richard Bohnenkamp; Anja ten Brinke; Andrew Bushell; Nathalie Cools; Edward K Geissler; Silvia Gregori; S Marieke van Ham; Catharien Hilkens; James A Hutchinson; Giovanna Lombardi; J Alejandro Madrigal; Natalia Marek-Trzonkowska; Eva M Martinez-Caceres; Maria Grazia Roncarolo; Silvia Sanchez-Ramon; Aurore Saudemont; Birgit Sawitzki
Journal:  Sci Transl Med       Date:  2015-09-09       Impact factor: 17.956

Review 2.  TNF-alpha: an activator of CD4+FoxP3+TNFR2+ regulatory T cells.

Authors:  Xin Chen; Joost J Oppenheim
Journal:  Curr Dir Autoimmun       Date:  2010-02-18

3.  Interleukin 6 induces cell proliferation of clear cell renal cell carcinoma by suppressing hepaCAM via the STAT3-dependent up-regulation of DNMT1 or DNMT3b.

Authors:  Zhen Quan; Yunfeng He; Chunli Luo; Yang Xia; Yan Zhao; Nanjing Liu; Xiaohou Wu
Journal:  Cell Signal       Date:  2017-01-16       Impact factor: 4.315

Review 4.  TNFR2: A Novel Target for Cancer Immunotherapy.

Authors:  Éva S Vanamee; Denise L Faustman
Journal:  Trends Mol Med       Date:  2017-10-12       Impact factor: 11.951

Review 5.  The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases.

Authors:  David Klatzmann; Abul K Abbas
Journal:  Nat Rev Immunol       Date:  2015-04-17       Impact factor: 53.106

6.  Selective tumor necrosis factor receptor I blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritis.

Authors:  Fiona E McCann; Dany P Perocheau; Gerhard Ruspi; Katrina Blazek; Marie L Davies; Marc Feldmann; Jonathan L E Dean; A Allart Stoop; Richard O Williams
Journal:  Arthritis Rheumatol       Date:  2014-10       Impact factor: 10.995

7.  Treg cell function in rheumatoid arthritis is compromised by ctla-4 promoter methylation resulting in a failure to activate the indoleamine 2,3-dioxygenase pathway.

Authors:  Adam P Cribbs; Alan Kennedy; Henry Penn; Jordan E Read; Parisa Amjadi; Patricia Green; Khaja Syed; Szymon W Manka; Fionula M Brennan; Bernard Gregory; Richard O Williams
Journal:  Arthritis Rheumatol       Date:  2014-09       Impact factor: 10.995

8.  Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial.

Authors:  Ronald F van Vollenhoven; Edward Clark Keystone; Vibeke Strand; Cesar Pacheco-Tena; Jiří Vencovský; Frank Behrens; Arthur Racewicz; Daniela Zipp; Faiza Rharbaoui; Ralf Wolter; Luise Knierim; Rainer Schmeidl; Xuefei Zhou; Silke Aigner; Benjamin Dälken; Andrea Wartenberg-Demand
Journal:  Ann Rheum Dis       Date:  2018-01-17       Impact factor: 19.103

9.  Selective Activation of Tumor Necrosis Factor Receptor II Induces Antiinflammatory Responses and Alleviates Experimental Arthritis.

Authors:  Roman Fischer; Marcel Proske; Maëlle Duffey; Hubert Stangl; George F Martinez; Nathalie Peters; Alexandra Kraske; Rainer H Straub; John R Bethea; Roland E Kontermann; Klaus Pfizenmaier
Journal:  Arthritis Rheumatol       Date:  2018-03-11       Impact factor: 10.995

10.  Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo.

Authors:  Xuyu Zhou; Samantha L Bailey-Bucktrout; Lukas T Jeker; Cristina Penaranda; Marc Martínez-Llordella; Meredith Ashby; Maki Nakayama; Wendy Rosenthal; Jeffrey A Bluestone
Journal:  Nat Immunol       Date:  2009-07-26       Impact factor: 25.606
  10 in total
  1 in total

Review 1.  Organ-on-a-Chip for Cancer and Immune Organs Modeling.

Authors:  Wujin Sun; Zhimin Luo; Junmin Lee; Han-Jun Kim; KangJu Lee; Peyton Tebon; Yudi Feng; Mehmet R Dokmeci; Shiladitya Sengupta; Ali Khademhosseini
Journal:  Adv Healthc Mater       Date:  2019-01-03       Impact factor: 9.933
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.